NEW YORK, Oct. 27, 2022 /PRNewswire/ -- The nucleic acid amplification market size is set to grow by USD 1.47 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 7.73% from 2021 to 2026. The increasing R&D activities at academic institutes and medical organizations are driving the nucleic acid amplification market growth. However, factors such as a lack of skilled workforce to handle may challenge the market growth.
Technavio offers an up-to-date analysis of the overall market environment and the current global market scenario. View FREE PDF Sample Report
- Technique
- Target amplification: The target amplification segment will be the largest contributor to market growth during the forecast period. This technique is used for molecular biology diagnoses that are needed to required to carry out biotechnology research. Pharmaceutical companies are opting for this technique to discover and develop new drugs. These factors, in turn, will propel the global nucleic acid amplification market growth during the forecast period.
- Probe amplification
- Signal amplification
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
The nucleic acid amplification market is fragmented, and the vendors are deploying growth strategies such as innovative product offerings to compete in the market. The market is highly competitive, with the presence of numerous prominent vendors. These vendors have established a major market presence. The competition will intensify with the rise in demand for nucleic acid amplification from biotechnology and pharmaceutical companies. Vendors should continuously innovate their offerings and build capabilities due to low service differentiation.
This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now for detailed information about vendors
Some of the major vendors of the nucleic acid amplification market include Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd.
- Nucleic Acid Amplification Market size
- Nucleic Acid Amplification Market trends
- Nucleic Acid Amplification Market industry analysis
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Basic Plan" billed annually at USD 5000. View 100 reports and download 5 reports monthly!
- CAGR of the market during 2022-2026
- Detailed information on factors that will assist nucleic acid amplification market growth during the next five years
- Estimation of the size of the nucleic acid amplification market and its contribution to the parent market
- Forecasts on upcoming trends and changes in consumer behavior
- The growth of the nucleic acid amplification market
- Analysis of the competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of nucleic acid amplification market vendors
Nucleic Acid Labeling Market by Application, End-user, and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by application (oligonucleotide labeling, in-situ hybridization, southern and northern blotting, and others), end-user (diagnostic centers, research centers, and hospitals), and geography (North America, Europe, Asia, and Rest of World (ROW)). 38% of the market's growth will originate from North America during the forecast period. The market share growth in the oligonucleotide labeling segment will be significant.
Amino Acid Analyzer for Industrial, Preclinical, and Clinical Usage Market by Type, Application, and Geography - Forecast and Analysis 2021-2025: This report extensively covers segmentation by type (automatic and manual), application (clinical and pharmaceutical, food and beverages, and others), and geography (North America, Europe, Asia, and ROW). 38% of the market's growth will originate from North America during the forecast period. The market share growth by the clinical and pharmaceutical segment will be significant.
Nucleic Acid Amplification Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.73% |
Market growth 2022-2026 |
USD 1.47 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.3 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd. |
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse Health Care Market Reports
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Technique
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Technique
- 5.1 Market segments
- Exhibit 24: Chart on Technique - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Technique - Market share 2021-2026 (%)
- 5.2 Comparison by Technique
- Exhibit 26: Chart on Comparison by Technique
- Exhibit 27: Data Table on Comparison by Technique
- 5.3 Target amplification - Market size and forecast 2021-2026
- Exhibit 28: Chart on Target amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Target amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Target amplification - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Target amplification - Year-over-year growth 2021-2026 (%)
- 5.4 Probe amplification - Market size and forecast 2021-2026
- Exhibit 32: Chart on Probe amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Probe amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Probe amplification - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Probe amplification - Year-over-year growth 2021-2026 (%)
- 5.5 Signal amplification - Market size and forecast 2021-2026
- Exhibit 36: Chart on Signal amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Signal amplification - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Signal amplification - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Signal amplification - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Technique
- Exhibit 40: Market opportunity by Technique ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 89: Abbott Laboratories - Overview
- Exhibit 90: Abbott Laboratories - Business segments
- Exhibit 91: Abbott Laboratories - Key news
- Exhibit 92: Abbott Laboratories - Key offerings
- Exhibit 93: Abbott Laboratories - Segment focus
- 10.4 Becton Dickinson and Co.
- Exhibit 94: Becton Dickinson and Co. - Overview
- Exhibit 95: Becton Dickinson and Co. - Business segments
- Exhibit 96: Becton Dickinson and Co. - Key news
- Exhibit 97: Becton Dickinson and Co. - Key offerings
- Exhibit 98: Becton Dickinson and Co. - Segment focus
- 10.5 bioMerieux SA
- Exhibit 99: bioMerieux SA - Overview
- Exhibit 100: bioMerieux SA - Business segments
- Exhibit 101: bioMerieux SA - Key offerings
- Exhibit 102: bioMerieux SA - Segment focus
- 10.6 Hologic Inc.
- Exhibit 103: Hologic Inc. - Overview
- Exhibit 104: Hologic Inc. - Business segments
- Exhibit 105: Hologic Inc. - Key news
- Exhibit 106: Hologic Inc. - Key offerings
- Exhibit 107: Hologic Inc. - Segment focus
- 10.7 LGC Ltd.
- Exhibit 108: LGC Ltd. - Overview
- Exhibit 109: LGC Ltd. - Product / Service
- Exhibit 110: LGC Ltd. - Key offerings
- 10.8 Meridian Bioscience Inc.
- Exhibit 111: Meridian Bioscience Inc. - Overview
- Exhibit 112: Meridian Bioscience Inc. - Business segments
- Exhibit 113: Meridian Bioscience Inc. - Key offerings
- Exhibit 114: Meridian Bioscience Inc. - Segment focus
- 10.9 New England Biolabs Inc.
- Exhibit 115: New England Biolabs Inc. - Overview
- Exhibit 116: New England Biolabs Inc. - Product / Service
- Exhibit 117: New England Biolabs Inc. - Key news
- Exhibit 118: New England Biolabs Inc. - Key offerings
- 10.10 OptiGene Ltd.
- Exhibit 119: OptiGene Ltd. - Overview
- Exhibit 120: OptiGene Ltd. - Product / Service
- Exhibit 121: OptiGene Ltd. - Key offerings
- 10.11 Promega Corp.
- Exhibit 122: Promega Corp. - Overview
- Exhibit 123: Promega Corp. - Product / Service
- Exhibit 124: Promega Corp. - Key offerings
- 10.12 Quidel Corp.
- Exhibit 125: Quidel Corp. - Overview
- Exhibit 126: Quidel Corp. - Product / Service
- Exhibit 127: Quidel Corp. - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 128: Inclusions checklist
- Exhibit 129: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 130: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 131: Research methodology
- Exhibit 132: Validation techniques employed for market sizing
- Exhibit 133: Information sources
- 11.5 List of abbreviations
- Exhibit 134: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article